MedTrace Logo

BOTOX® Cosmetic and Skin Health.

NCT05138835 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2023-05-31

No results posted yet for this study

Summary

This is a two cohort, randomized, double blind, single center study to evaluate the effects of Botox Cosmetic (BTX) on sebum protection. Thirty-four female subjects with moderate-to-high skin sebum concentration will be recruited and randomized in a 1:1 ratio to treatment groups.

Conditions

  • Oily Skin

Interventions

DRUG

Botox Cosmetic

BOTOX® Cosmetic is approved and commercially available for use in Canada. BOTOX® Cosmetic is a prescription medicine that is injected into muscles and used to temporarily improve the look of moderate to severe frown lines between the eyebrows, crow's feet lines, and forehead lines in adults.

Sponsors & Collaborators

  • Andreas Nikolis

    lead OTHER

Principal Investigators

  • Andreas Nikolis · Erevna Innovations Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-11
Primary Completion
2022-11-11
Completion
2022-12-11

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05138835 on ClinicalTrials.gov